2041-19: Pharmacogenomics and Psychiatry: Current Trends and Practical Experience

3 (1 vote)

2041-19:  Pharmacogenomics and Psychiatry: Current Trends and Practical Experience

This presentation introduces the current state of the science regarding the diagnosis and treatment of mental illness, genetics as related to genotype and phenotype, and the current literature regarding pharmacogenomic testing and its application for the appropriate individualized pharmacological treatment for the psychiatric mental health patient.

  Jessica Whelan, FPMHNP-BC, RN, BSN, MSN, FMHNP

Disclosures:  The presenter has indicated a significant financial interest or other affiliation with Allergan, Otsuka, Avanir, Takeda and Genomind. Off-label use of medications will be discussed during this presentation. The activity planners have no conflicts of interest to disclose.

Session Length:
  36 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

  • Compare mental health treatment methodologies with and without pharmacogenomic testing.

Keywords:  Pharmacogenomic, Genetic Testing, Personalized Medicine

Nursing Continuing Professional Development:
0.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 33rd Annual Conference
New Orleans, Louisiana

The contact hours for this session expire:  November 30, 2021

Components visible upon registration.